| RE46276 |
Triazolo(4,5-D)pyrimidine compounds |
David Hardem, Anthony Ingall, Brian Springthorpe, Simon Guile |
2017-01-17 |
|
| 8143261 |
Thiazolo (4,5-D) pyrimidine compounds |
Roger Bonnert, Simon Fraser Hunt, Iain Walters |
2012-03-27 |
$3,525,000 |
| 8012979 |
Compounds and their uses 707 |
Matthew Hallam, Barrie Martin, Piotr Raubo, Bryan Roberts, Stephen St-Gallay |
2011-09-06 |
$3,679,000 |
| 7408065 |
P2X7 receptor antagonists and their use |
Richard Evans, Christine Eyssade, Rhonan Ford, Barrie Martin, Toby Thompson |
2008-08-05 |
$10,327,000 |
| 7250419 |
Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
David Hardern, Anthony Ingall, Brian Springthorpe, Simon Guile |
2007-07-31 |
$36,849,000 |
| 7132457 |
Adamantane derivatives |
Lilian Alcaraz, Mark Furber, Michael Mortimore, Austen Pimm, Philip Thorne |
2006-11-07 |
$11,413,000 |
| 6974868 |
Compounds |
David Hardern, Anthony Ingall, Brian Springthorpe, Simon Guile |
2005-12-13 |
$11,892,000 |
| 6958344 |
Pyrimidine compounds and their use as modulators of chemokine receptor activity |
Roger Bonnert, Peter Cage, Fraser Hunt, Iain Walters |
2005-10-25 |
$12,058,000 |
| 6881754 |
Adamantane derivatives |
Lilian Alcaraz, Moya Caffrey, Mark Furber, Timothy Jon Luker, Michael Mortimore +2 more |
2005-04-19 |
$17,011,000 |
| 6806273 |
Compounds |
Rupert Austin, Andrew Baxter, Roger Bonnert, Fraser Hunt, Elizabeth Kinchin |
2004-10-19 |
$7,254,000 |
| 6790850 |
Thiazolo(4,5-d)pyrimidine compounds |
Roger Bonnert, Simon Fraser Hunt, Iain Walters |
2004-09-14 |
$14,327,000 |
| 6525060 |
Triazolo(4,5-d)pyrimidine compounds |
David Hardern, Anthony Ingall, Brian Springthorpe, Simon Guile |
2003-02-25 |
$5,431,000 |
| 6369064 |
Triazolo(4,5-d)pyrimidine compounds |
Roger Brown, Garry Pairaudeau, Brian Springthorpe, Stephen Thom |
2002-04-09 |
$7,882,000 |
| 6297232 |
Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments |
Roger Bonnert, Anthony Ingall, Brian Springthorpe |
2001-10-02 |
$30,815,000 |
| 6251910 |
1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists |
Simon Guile, Anthony Ingall, Brian Springthorpe |
2001-06-26 |
$10,685,000 |
| 5747496 |
Inhibitors of platelet aggregation |
David Cox, Anthony Ingall |
1998-05-05 |
|
